165 related articles for article (PubMed ID: 27298454)
1. Teaching NeuroImages: Vanishing white matter ovarioleukodystrophy.
Mukerji SS; Eichler FS
Neurology; 2016 Jun; 86(24):e248. PubMed ID: 27298454
[No Abstract] [Full Text] [Related]
2. Teaching NeuroImages: Adult-onset vanishing white matter disease.
Villar-Quiles RN; Delgado-Suárez C; Jorquera-Moya M; Arpa-Gutiérrez J; Ortega-Suero G
Neurology; 2018 Mar; 90(12):e1091-e1092. PubMed ID: 29555891
[No Abstract] [Full Text] [Related]
3. Ovarioleukodystrophy due to EIF2B5 mutations.
Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
[TBL] [Abstract][Full Text] [Related]
4. Ovarioleukodystrophy: report of a case with the c.338G>A (p.Arg113His) mutation on exon 3 and the c.896G>A (p.Arg299His) mutation on exon 7 of the EIF2B5 gene.
Imam I; Brown J; Lee P; Thomas PK; Manji H
BMJ Case Rep; 2011 Mar; 2011():. PubMed ID: 22699478
[TBL] [Abstract][Full Text] [Related]
5. Adult-onset vanishing white matter disease with the EIF2B2 gene mutation presenting as menometrorrhagia.
Wei C; Qin Q; Chen F; Zhou A; Wang F; Zuo X; Chen R; Lyu J; Jia J
BMC Neurol; 2019 Aug; 19(1):203. PubMed ID: 31438897
[TBL] [Abstract][Full Text] [Related]
6. A novel hypomorphic splice variant in EIF2B5 gene is associated with mild ovarioleukodystrophy.
Rodríguez-Palmero A; Schlüter A; Verdura E; Ruiz M; Martínez JJ; Gourlaouen I; Ka C; Lobato R; Casasnovas C; Le Gac G; Fourcade S; Pujol A
Ann Clin Transl Neurol; 2020 Sep; 7(9):1574-1579. PubMed ID: 33245593
[TBL] [Abstract][Full Text] [Related]
7. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
Alsalem A; Shaheen R; Alkuraya FS
Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
[TBL] [Abstract][Full Text] [Related]
8. [Leukoencephalopathy with vanishing white matter: a clinical case of adult onset].
Pato Pato A; Lorenzo González JR; Cimas Hernando I; Rodríguez-Constenla I
Neurologia; 2009 Sep; 24(7):504-5. PubMed ID: 21469262
[No Abstract] [Full Text] [Related]
9. Epilepsy and ovarian failure: Two cases of adolescent-onset ovarioleukodystrophy.
Herrera-García JD; Guillen-Martínez V; Creus-Fernández C; Mínguez-Castellanos A; Carnero Pardo C
Clin Neurol Neurosurg; 2018 Feb; 165():94-95. PubMed ID: 29331873
[TBL] [Abstract][Full Text] [Related]
10. A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.
Ghezzi L; Scarpini E; Rango M; Arighi A; Bassi MT; Tenderini E; De Riz M; Jacini F; Fumagalli GG; Pietroboni AM; Galimberti D; Bresolin N
Neurology; 2012 Nov; 79(20):2077-8. PubMed ID: 23115207
[TBL] [Abstract][Full Text] [Related]
11. Adult-onset vanishing white matter disease with novel missense mutations in a subunit of translational regulator, EIF2B4.
Kanbayashi T; Saito F; Matsukawa T; Oba H; Hokkoku K; Hatanaka Y; Tsuji S; Sonoo M
Clin Genet; 2015 Oct; 88(4):401-3. PubMed ID: 25600065
[No Abstract] [Full Text] [Related]
12. Long-Standing Psychiatric Features as the Only Clinical Presentation of Vanishing White Matter Disease.
Accogli A; Brais B; Tampieri D; La Piana R
J Neuropsychiatry Clin Neurosci; 2019; 31(3):276-279. PubMed ID: 31046592
[No Abstract] [Full Text] [Related]
13. AARS2-related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases.
Taglia I; Di Donato I; Bianchi S; Cerase A; Monti L; Marconi R; Orrico A; Rufa A; Federico A; Dotti MT
Acta Neurol Scand; 2018 Oct; 138(4):278-283. PubMed ID: 29749055
[TBL] [Abstract][Full Text] [Related]
14. [Spasticity and progressive ataxia due to vanishing white matter].
Paez-Granda D; Jimenez-Sanchez A; Fernandez-Hernandez C; Serrano-Garcia C
Rev Neurol; 2017 Dec; 65(12):563-564. PubMed ID: 29235619
[TBL] [Abstract][Full Text] [Related]
15. An unmasked mutation of EIF2B2 due to submicroscopic deletion of 14q24.3 in a patient with vanishing white matter disease.
Shimada S; Miya K; Oda N; Watanabe Y; Kumada T; Sugawara M; Shimojima K; Yamamoto T
Am J Med Genet A; 2012 Jul; 158A(7):1771-7. PubMed ID: 22678813
[TBL] [Abstract][Full Text] [Related]
16. Vanishing white matter disease with mutations in EIF2B5 gene.
Sharma S; Ajij M; Singh V; Aneja S
Indian J Pediatr; 2015 Jan; 82(1):93-5. PubMed ID: 25230711
[TBL] [Abstract][Full Text] [Related]
17. Adult-onset leukoencephalopathies with vanishing white matter with novel missense mutations in EIF2B2, EIF2B3, and EIF2B5.
Matsukawa T; Wang X; Liu R; Wortham NC; Onuki Y; Kubota A; Hida A; Kowa H; Fukuda Y; Ishiura H; Mitsui J; Takahashi Y; Aoki S; Takizawa S; Shimizu J; Goto J; Proud CG; Tsuji S
Neurogenetics; 2011 Aug; 12(3):259-61. PubMed ID: 21484434
[No Abstract] [Full Text] [Related]
18. Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.
La Piana R; Vanderver A; van der Knaap M; Roux L; Tampieri D; Brais B; Bernard G
Arch Neurol; 2012 Jun; 69(6):765-68. PubMed ID: 22312164
[TBL] [Abstract][Full Text] [Related]
19. Teaching NeuroImages: rapidly progressive leukoencephalopathy in mitochondrial complex I deficiency.
Baertling F; Schaper J; Mayatepek E; Distelmaier F
Neurology; 2013 Jul; 81(2):e10-1. PubMed ID: 23836946
[No Abstract] [Full Text] [Related]
20. Vanishing white matter disease presenting as opsoclonus myoclonus syndrome in childhood--a case report and review of the literature.
Klingelhoefer L; Misbahuddin A; Jawad T; Mellers J; Jarosz J; Weeks R; Ray Chaudhuri K
Pediatr Neurol; 2014 Jul; 51(1):157-64. PubMed ID: 24938145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]